Jazz Pharmaceuticals

JAZZ • NASDAQ • Stock Fundamentals

Jazz Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Renee D. Gala, with a market cap of $14.8B.

Market Cap$14.8B

Employees2.8K

CEORenee D. Gala

CountryIreland

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Jazz Pharmaceuticals

Jazz Pharmaceuticals (JAZZ) has a market capitalization of $14.8B and trades on NASDAQ.

Jazz Pharmaceuticals has approximately 2,800 employees.